Kidney Stone Risk in Spaceflight: Prevention, Recognition and Follow-up
Also: renal stones spaceflight · nephrolithiasis astronaut · hypercalciuria microgravity · potassium citrate astronaut
Gravity FieldsHostile/Closed EnvironmentRenal & GUMusculoskeletalPreflight & TrainingIn-flightPostflight RecoveryLifetime SurveillanceLEO long-durationCislunar / Lunar orbitLunar surfaceMars transit & surfaceClinicianResearcher
- Spaceflight raises urinary supersaturation of stone-forming salts: bone loss increases urinary calcium and crews produce much less urine (47% lower early and 39% lower late in long missions in one study). ◆◆◆◆ High · F
- No symptomatic kidney stones have occurred in flight among U.S. ISS crew to date (one possible cosmonaut case), but the post-flight year carries an estimated 2–7× higher incidence than preflight. ◆◆◇◇ Low · F C
- Hydration is the key countermeasure — modeling suggests about 3.2 L/day of water intake to bring risk back to preflight levels; limit sodium and animal protein; potassium citrate reduced risk markers in a flight study. ◆◆◆◇ Moderate · F C
- Ultrasound is the in-flight diagnostic tool; NASA also surveys astronauts on the ground with renal ultrasound. ◆◆◆◇ Moderate · F E
- For clinicians: in a recently returned flyer with flank pain or hematuria, think stone; ask about bone-loss history and push fluids for at least a year. ◆◆◆◇ Moderate · E
Proposed certainty (◆ High → ◇ Very low) and evidence-type tags: F flight · A analog · M model/animal · C computational · E expert/operational/standards. Grades are AI-proposed and pending medical reviewer confirmation. How we grade.
What to do
Before a long flight
- Ask about prior stones — a personal history of symptomatic stones is a clear risk factor [1].
- Baseline renal ultrasound (NASA surveys every active astronaut annually and pre-/post-flight) [1]; consider 24-hour urine risk profile in those with history.
- Counsel: high fluid intake target, lower sodium, moderate animal protein, low-oxalate choices if indicated [1].
- Optimize bone protection (resistance exercise, vitamin D) — less bone resorption means less urinary calcium [1][5].
In a recently returned flyer
- Flank pain, hematuria, dysuria, or unexplained abdominal pain → treat as possible stone: urinalysis, renal ultrasound first (no radiation), low-dose CT if needed [1].
- Keep fluids high for at least the first post-flight year — the estimated incidence is 2–7× preflight in that period [1].
- Urology referral for obstruction, infection, or recurrent stones; metabolic workup (24-h urine) if a stone occurs.
Red flags
- Fever with flank pain (obstructed infected kidney) — emergency decompression.
- Anuria or solitary kidney with obstruction.
- Uncontrolled pain or vomiting.
Overview: why risk goes up
| Factor | What happens in flight |
|---|---|
| Bone loss | Calcium is released from bone and excreted in urine [1][5] |
| Low urine volume | In long-duration crew, urine volume was 47% lower before flight day 30 and 39% lower after day 60 [1] |
| Urine chemistry | Supersaturation of brushite and calcium oxalate rose by 150% and 115% during flight [1][3] |
| Diet | High sodium and animal protein increase risk [1] |
Risk of stone formation rises when urine volume falls below 1.5 L/day; an effective hydration countermeasure should produce 2.5–3 L/day of urine. A NASA model estimated water intake would need to increase to about 3.2 L/day to approach the preflight calcium oxalate risk [1].
How common are stones?
- In flight: no symptomatic kidney stones in U.S. ISS crew to date; one possible episode in a cosmonaut (severe lower abdominal pain that resolved, later attributed to renal colic) [1].
- After flight: estimated incidence approaches 2–7× preflight levels at 1 year post-flight — still well below terrestrial recurrent stone formers (10–45× the astronaut preflight rate) [1].
- Ultrasound surveillance: 282 studies in 73 astronauts (30 paired pre/post-flight) showed no increase in “mineralized renal material” after flight (pending formal publication) [1].
Countermeasures
| Countermeasure | Evidence | Certainty |
|---|---|---|
| Fluids | Mechanistically well understood; terrestrial meta-analysis: each 500 mL more water associated with lower stone risk (RR 0.93) [1] | ◆◆◆ high (terrestrial) |
| Sodium and protein moderation | Recommended by NASA [1] | ◆◆ moderate |
| Potassium citrate | Flight study in 30 crewmembers: 20 mEq/day reduced calcium oxalate risk markers [2]; may be useful in high-risk individuals [1] | ◆◆ moderate |
| Bone protection (resistance exercise ± bisphosphonate) | Reduces bone resorption, the source of urinary calcium [1][3] | ◆ low–moderate |
| IV fluids for severe motion sickness | Considered to prevent early dehydration [1] | ◆ expert |
Mission-type differences
| Mission | Notes |
|---|---|
| LEO short | Early low urine volume and motion sickness; stone formation unlikely within days |
| LEO long | Hypercalciuria builds; evacuation possible if a stone obstructs |
| Lunar / Mars | No evacuation; a stone in transit could be mission-threatening; ultrasound and drugs must suffice [1] |
Terrestrial parallels
- Immobilization hypercalciuria (spinal cord injury, prolonged bed rest, fractures) — same mechanism.
- Recurrent stone formers — same prevention toolkit (fluids, citrate, sodium restriction).
- Hot-climate and military deployment stones — low urine volume as the driver.
Gaps
- Whether ultrasound criteria work the same in flight (CO2 may weaken the “twinkle” artifact) [1].
- Best in-flight treatment for an obstructing stone without evacuation (e.g., ultrasound-guided stone repositioning) pending verification.
- Long-term post-flight stone incidence in larger cohorts.
Deeper dive: how citrate works
Oral citrate is metabolized to an alkali load, raising urinary citrate and pH. Citrate complexes calcium, lowering supersaturation of calcium oxalate and brushite; higher pH also ionizes uric acid to more soluble urate. Side effects are uncommon and mainly gastrointestinal [1].
Commercial spaceflight notes
For short commercial flights the main step is hydration and asking about stone history. For participants with recurrent stones planning long stays, consider a urology consult and 24-hour urine before flight.
Clinical pearls
- “Bone + stone”: the calcium lost from bone in flight ends up in the urine.
- Recently returned + flank pain = stone until proven otherwise; ultrasound first.
Evidence profile
- Overall certainty
- ◆◆◆◇ Moderate (proposed)
- Evidence types
- F · Flight dataC · ComputationalE · Expert / operational / standards
- Literature through
- 2026-10-14
NASA-STD-3001 requirements referenced 4
| Requirement | Title | Plain-language meaning |
|---|---|---|
| [V1 4019]–[V1 4020] | Pre-Mission Nutritional Status / In-Mission Nutrient Intake | Diet assessed and must provide 100% of nutrient and energy needs. |
| [V1 4027] | In-Mission Bone Mineral Density Maintenance | Bone protection also limits urinary calcium. |
| [V2 6109] | Water Quantity | Vehicles must provide enough potable water for crew needs. |
| [V1 3004] | In-Mission Medical Care | Diagnostic and treatment capability (ultrasound, analgesia, urinary drainage). |
IDs as published in NASA-STD-3001 Vol. 1 Rev C (2023-09-15) and NASA-STD-3001 Vol. 2 Rev F (2026-07-14). NASA-STD-3001 binds NASA programs; it is not a regulation for commercial flights. Paraphrased; read the standard for exact wording. Standards quick reference.
References 6
- NASA Human Research Program. Evidence Report: Risk of Renal Stone Formation (2024). humanresearchroadmap.nasa.gov/evidence/other/2024%20Renal%20… NASA F
- Whitson PA, Pietrzyk RA, Jones JA, Nelman-Gonzalez M, Hudson EK, Sams CF. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight. J Urol. 2009;182(5):2490-2496. doi:10.1016/j.juro.2009.07.010 PMID:19765769 Peer-reviewed F
- Smith SM, Heer M, Shackelford LC, Sibonga JD, Spatz J, Pietrzyk RA, Hudson EK, Zwart SR. Bone metabolism and renal stone risk during International Space Station missions. Bone. 2015;81:712-720. doi:10.1016/j.bone.2015.10.002 PMID:26456109 Peer-reviewed F
- NASA OCHMO. Spaceflight Experience and Medical Care. Technical Brief OCHMO-TB-033. www.nasa.gov/wp-content/uploads/2023/12/ochmo-tb-033-spacefl… NASA E
- NASA OCHMO. Bone Loss. Medical Technical Brief OCHMO-MTB-013, Rev D (2026). www.nasa.gov/wp-content/uploads/2026/02/ochmo-mtb-013-bone-l… NASA E
- NASA OCHMO. NASA-STD-3001, Volume 1, Revision C (2023). www.nasa.gov/wp-content/uploads/2023/11/nasa-std-3001-vol-1-… Standard E
Links and DOI metadata were machine-checked on 2026-10-14 (URL resolves; DOI title/journal/year matched via Crossref). Human verification of each cited claim against its source is still required before review. NASA documents are U.S. Government works (public domain) and are summarized with attribution; journal articles are summarized, not reproduced.
Article info
- Authors
- Pending (AI-assisted draft)
- Reviewer
- Pending review
- Last reviewed
- Pending review
- Literature through
- 2026-10-14
- AI-assisted
- Yes (disclosed)
- COI
- Pending
- License
- CC BY-SA 4.0
- Use
- Educational only · Disclaimer
- Cite this version
- Pending first edition